ロード中...
A meta-analysis of the comparing of the first-generation and next-generation TKIs in the treatment of NSCLC
BackgroundThe current standard approach to the treatment of patients with non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)—sensitizing mutations has been the treatment with a first-generation EGFR-TKIs. While, with resistance develope...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AIMS Press
2019-06-01
|
| シリーズ: | Mathematical Biosciences and Engineering |
| 主題: | |
| オンライン･アクセス: | https://www.aimspress.com/article/10.3934/mbe.2019283?viewType=HTML |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|